Comparison of intralesional triamcinolone acetonide injection (TA) and curretage on treatment of chalazio
Phase 3
- Conditions
- Diseases of the eye and adnexa.Chalazion
- Registration Number
- IRCT201606156033N5
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
all patients with chronic chalazion which unresponsive to medical treatment.
Exclusion criteria: patients with chalazia which have atypical features, concurrent eyelid infection, multiple chalazia on one eyelid, history of previous treatment by TA or I and C
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreased size of chalazion. Timepoint: 45 days. Method of measurement: Size of chalazion was measured by ruller and 90% decrease in the size of chalazion was defined as success.
- Secondary Outcome Measures
Name Time Method Recurrence of chalazion. Timepoint: 45 days. Method of measurement: Observation.